The influence of short-term therapy of continous positive airway pressure (CPAP) on exhaled nitric oxide concentration (FENO ) in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005
Exhaled nitric oxide in obstructive sleep apnea (OSA) patients: short and long term response to automatic positive airway pressure (APAP) therapy Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Exhaled breath markers in patients with obstructive sleep apnea (OSA): baseline assessment and the impact of treatment with nasal continuous positive airway pressure Source: Eur Respir J 2005; 26: Suppl. 49, 355s Year: 2005
Alveolar but not airway fractional exhaled nitric oxide concentration (FENO) is decreased in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 467s Year: 2003
The role of inflammatory mediator in exhaled breath condensate of obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004
Exhaled breath condensate (EBC): what is sampled and how should it be collected? (recommendations and open issues) Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate Year: 2007
Concentration of exhaled nitric oxide (FENO ) in patients with obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004
Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003
Measurement of exhaled breath temperature (EBT) in COPD patients Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009
Factors influencing airway inflammation measured by exhaled NO levels in a population with obstructive sleep apnea syndrome (OSA) Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Oxidative stress in children with OSAS: 8-isoprostane values comparison in urine and exhaled breath condensate (EBC) Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II Year: 2015
Nitrite/nitrate in exhaled breath condensate (EBC) of patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006
The 3-nitrothyrozine and total nitrate/nitrite (TNN) levels in exhaled breath condensate (EBC) in patients with bronchial asthma (BA) Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Longitudinal analysis between exhaled nitric oxide (FeNO), inflammatory markers (IM) in exhaled breath condensate (EBC), lung function, and control/severity of childhood asthma Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007
Decreased plasma levels of nitric oxide (NO) derivatives in obstructive sleep apnea (OSA): response to automatic positive airway pressure (APAP) therapy Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007
Influence of nasal obstruction (NO) on obstructive sleep apnea (OSA) severity and continuous positive airway pressure (CPAP) adaptation problems Source: Annual Congress 2010 - The upper airway and oral appliances Year: 2010
Exhaled breath condensate pH Source: Eur Respir Monogr 2010; 49: 173-182 Year: 2010
Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008
Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018
The study of the activity of antioxidant enzymes in exhaled breath condensate (EBC) in patients with COPD Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020